Aminobisphosphonates as New Weapons for #947; #948; T Cell-Based Immunotherapy of Cancer

E-ISSN： 1875-533x|15|12|1147-1153

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.12, 2008-05, pp. : 1147-1153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New frontiers in cell-based immunotherapy of cancer

By Milco D'Elios Mario Del Prete Gianfranco Amedei Amedeo

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 623-641

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell-based approaches to cancer immunotherapy

By Morse M.A. Lyerly H.K.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 10, 1998-10 ,pp. : 1617-1627

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Vaccines for Cervical Cancer: Dendritic Cell-Based Immunotherapy

Current Pharmaceutical Design, Vol. 11, Iss. 27, 2005-10 ,pp. : 3485-3500

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Pyrophosphate-Containing Compounds that Stimulate V&ggr;V&dgr;2 T Cells: Application to Cancer Immunotherapy

Medicinal Chemistry, Vol. 3, Iss. 1, 2007-01 ,pp. : 85-99

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic Cell-Based Immunotherapy in Thyroid Malignancies

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite